@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev
@MarkHFierce: Our coverage of the 2012 BIO International Convention continues. Roundup | Follow @MarkHFierce
> The rise in molecular diagnostics testing helped contribute to 96,000 biosciences jobs created in the U.S. from 2001 through 2010, even as private-sector jobs otherwise declined, according to a new report from the Biotechnology Industry Organization and the research firm Batelle. Story
> Investors are driving D. Medical Industries shares higher after the Israeli company disclosed it is negotiating to possibly buy a diabetes devices company. Item
> Venture capitalists are increasingly turning to startups that make smartphone and tablet apps for doctor and hospital use, Bloomberg reports. Story
> AdeTherapeutics, a developer of products designed to reduce post-surgical adhesion complications, has hired a number of renowned physicians for its "clinical execution team." Release
> Massachusetts Institute of Technology researchers are working on developing sharper ultrasound imaging technology in a bid to improve the diagnostic tool. Story
Biotech News
@FierceBiotech: The Fierce team has landed in Boston. Check out our dedicated BIO2012 page. Special Coverage | Follow @FierceBiotech
@JohnCFierce: Thanks to Bernard Munos, Jim Burns, Jason Gardner, Jill Milne, Mene Pangalos and 300+ of my closest friends for a great conversation this a.m. | Follow @JohnCFierce
@RyanMFierce: Danish biotech Nuevolution snagged €11 Million in new financing round. Release | Follow @RyanMFierce
> Millennium wants to rival top 10 drugmakers in oncology. Story
> E&Y: Biotech looks stable, but warning signs cloud the future. Article
> Novartis, Emergent headline $400M HHS plan to combat health threats. News
> Roche, Seaside join forces against autism and Fragile X. More
> Biotech beats overall economy in jobs report. Item
Pharma News
@FiercePharma: Will Human Genome's bid deadline backfire? Or will GSK be thwarted by some secretive white knight? Report | Follow @FiercePharma
> With Brennan gone, AstraZeneca megamerger talk can resume. Article
> No overtime for pharma reps, Supreme Court says. Story
> Merck Serono's final answer: Geneva HQ will close. News
Biotech Research News
> In life sciences R&D, China is reaching for the stars. Editor's corner
> Pluristem's placental stem cells spur bone marrow growth. Story
> Genetic markers uncovered for rare children's brain tumor. Report
> Breakthrough: Human Microbiome Project maps healthy body microbes. More
Pharma Manufacturing News
> Amneal Pharmaceuticals quadruples manufacturing. Item
> Just about everyone agrees: drug shortages are a complex puzzle. Story
> Canadian Internet pharmacy leader faces federal charges. Article
And Finally... Royal DSM's ($DSM) plans to pay $360 million for Kensey Nash ($KNSY), a regenerative medicine-focused medical device company, and looks to close its offer within a few days. Release